The Center for Global Development Working Group on UNFPA’s Leadership Transition urges the UNFPA to sharpen its focus in pursuing the Programme of Action developed at the 1994 International Conference on Population and Development.
The time is right to reinvigorate UNFPA. Seventeen years after the groundbreaking ICPD meeting, UNFPA needs to make itself the lead agency for population, sexual and reproductive health, and reproductive rights in the UN system, as well as be more visible externally.
Once rich-world woes, non-communicable diseases such as diabetes and cancer account for half the burden of disease in the developing world. Yet Rachel Nugent finds that barely 3 percent of aid and philanthropic spending on health addresses this neglected health crisis.
In an increasingly interconnected world, drug resistance does not stop at a patient’s bedside—it threatens global health. The conclusions of the Center for Global Development’s Drug Resistance Working Group make clear the need for urgent action to address this growing crisis.
The Center for Global Development’s Drug Resistance Working Group urges pharmaceutical companies, governments, donors, global health institutions, health providers, and patients to collectively and immediately tackle this global health threat by implementing four key recommendations.
In this working paper, commissioned as part of CGD's Drug Resistance Working Group, Prashant Yadav analyzes how changes in supply-chain business practices could help fix the misaligned incentives that hinder worldwide access to high-quality medical goods.